About ADMA Biologics (ADMA)
ADMA Biologics, Inc. is a biopharmaceutical company. It develops, manufactures, and markets specialty plasma-based biologics for the treatment and prevention of infectious diseases. It is engaged in the development and commercialization of human plas... Read more
- USD15.69
- USD15.96
- USD15.47
- USD25.67
- -8.40%
- 474M
- 356.00
- 3.50M
- 3.8B
- 13.50
- -16.80%
- 21.30%
Stock News
1 hour ago
‘Risk management’ cuts usually come in pairs, says Goldman economist
MarketWatch
6 hours ago
The Oracle Of AI Or Waiting For An OpenAI Disaster? (Rating Upgrade)
SeekingAlpha
6 hours ago
Lightbridge: Robust Market Sentiment Overshadows Its Overvaluation Into 2026
SeekingAlpha
6 hours ago
NIE: Market Valuations Appear Stretched, But This Fund's Has Improved
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
